Adiponectin has anti‐inflammatory effects and is linked to diabetes and glycemic control. After periodontal therapy, increased adiponectin can improve insulin resistance and lower HbA1c. The adiponectin receptor agonist, AdipoAI, may reduce tissue inflammation and damage, suggesting potential for treating diabetes‐related periodontitis. This evidence concerns the gene ADIPOQ and Insulin resistance.